Invention Grant
- Patent Title: Method for screening pharmaceuticals for treatment of steatohepatitis using N-terminal dimerization of apoptosis signal-regulated kinase1
-
Application No.: US15821865Application Date: 2017-11-24
-
Publication No.: US10718755B2Publication Date: 2020-07-21
- Inventor: Hongliang Li
- Applicant: WUHAN UNIVERSITY
- Applicant Address: CN Wuhan
- Assignee: WUHAN UNIVERSITY
- Current Assignee: WUHAN UNIVERSITY
- Current Assignee Address: CN Wuhan
- Agency: Matthias Scholl P.C.
- Agent Matthias Scholl
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6d86dff com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6573bb0e
- Main IPC: G01N33/567
- IPC: G01N33/567 ; G01N33/50 ; C12Q1/48 ; C12N9/12 ; C07K14/00 ; C12N5/071
Abstract:
A method for screening a pharmaceutical compound for prevention, alleviation and/or treatment of steatohepatitis, the method including employing N-terminal dimerization of an apoptosis signal-regulated kinase 1 as a target.
Public/Granted literature
Information query
IPC分类:
